The firm has announced its readiness to implant a new device, Blindsight, into a human patient. The move comes as part of the company's broader mission to develop brain-computer interfaces (BCIs).

Building on these human genetic findings, insitro's CellML (TM) platform was used to screen genetically supported targets in primary human adipocytes using high-content imaging, transcriptomics, and ...

Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

European micro-mobility giant NAVEE is going global. Explore their new AI-enabled trailers, exoskeletons, and water flight ...

The evolution of AI-powered vehicle inspection has moved rapidly from experimental research to an essential pillar of the modern automotive ecosystem. Historically, vehicle checks were manual and ...

Sports Academy to support validation and population-scale insights through AMV -facilitated performance environments ...

New narrative-guided media intelligence transforms scattered digital memories into a searchable, story-aware personal ...

Assert AI, registered as Assert AI Inc. in the United States, today announced a year of strong business growth, product ...

Paramount Business Jets reports that advances in aviation tech enhance safety by improving turbulence prediction, situational ...

What is it when intelligence ceases to be something that a person is born with and is something that a person plugs? The ...

Dr. Berenika Maciejewicz, a triple-doctor and an expert in longevity, leads the company’s interdisciplinary team to ...